CONMED Insider Trades
NYSE: CNMDHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 2 · $161.09K
- Shares bought / sold
- 0 / 3.76K
- Net activity
- Net selling $161,091
CONMED insider activity
Over the last 12 months, CONMED insiders reported 17 transactions on SEC Form 4: 0 open-market purchases and 2 sales. Insiders bought $0 and sold $161,091 worth of stock, for net insider selling of $161,091. The largest seller was Garner Todd W, with $150,500 in reported sales.
The most recent filing shows Kelderman Kim (Director) reporting a transaction in 500 shares on Sep 8, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CNMD's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
CNMD insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 8, 2026 | Kelderman KimDirector | Option exercise | 500 | — | Form 4 |
| Jun 2, 2026 | Schwarzentraub Barbara JDirector | Option exercise | 668 | — | Form 4 |
| Jun 2, 2026 | Kaye MarkDirector | Option exercise | 668 | — | Form 4 |
| Jun 2, 2026 | Farkas CharlesDirector | Option exercise | 668 | — | Form 4 |
| Jun 2, 2026 | Council LaVerne HDirector | Option exercise | 668 | — | Form 4 |
| Jun 2, 2026 | Bronson David M.Director | Option exercise | 668 | — | Form 4 |
| Mar 6, 2026 | Lalomia BrentExecutive VP RA, QA | Tax withholding | 26 | $1.04K | Form 4 |
| Mar 6, 2026 | Lalomia BrentExecutive VP RA, QA | Option exercise | 75 | — | Form 4 |
| Feb 24, 2026 | Kaye MarkDirector | Option exercise | 152 | — | Form 4 |
| Nov 21, 2025 | Glaze RichardChief Information Officer | Sale | 257 | $10.59K | Form 4 |
| Nov 20, 2025 | Glaze RichardChief Information Officer | Tax withholding | 118 | $4.79K | Form 4 |
| Nov 20, 2025 | Glaze RichardChief Information Officer | Option exercise | 375 | — | Form 4 |
| Nov 6, 2025 | Garner Todd WExecutive Vice President & CFO | Sale | 3,500 | $150.50K | Form 4 |
| Nov 4, 2025 | Foust Hollie KGeneral Counsel & Corp Sec | Tax withholding | 1,114 | $50.92K | Form 4 |
| Nov 4, 2025 | Foust Hollie KGeneral Counsel & Corp Sec | Option exercise | 4,000 | — | Form 4 |
| Oct 31, 2025 | Garner Todd WExecutive Vice President & CFO | Tax withholding | 2,164 | $95.22K | Form 4 |
| Oct 31, 2025 | Garner Todd WExecutive Vice President & CFO | Option exercise | 7,500 | — | Form 4 |
| Sep 12, 2025 | Farkas CharlesDirector | Sale | 897 | $48.00K | Form 4 |
| Sep 12, 2025 | Farkas CharlesDirector | Sale | 1,103 | $59.05K | Form 4 |
| Aug 7, 2025 | Garner Todd WExecutive Vice President & CFO | Sale | 598 | $31.37K | Form 4 |
| Jun 3, 2025 | Farkas CharlesDirector | Option exercise | 479 | — | Form 4 |
| Jun 3, 2025 | Bronson David M.Director | Option exercise | 479 | — | Form 4 |
| Jun 3, 2025 | Concannon BrianDirector | Option exercise | 479 | — | Form 4 |
| Jun 3, 2025 | Council LaVerne HDirector | Option exercise | 479 | — | Form 4 |
| Jun 3, 2025 | Schwarzentraub Barbara JDirector | Option exercise | 479 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4